OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Neoadjuvant nivolumab and relatlimab in locally advanced MMR-deficient colon cancer: a phase 2 trial
P.G.M. de Gooyer, Y.L. Verschoor, L.D.W. van den Dungen, et al.
Nature Medicine (2024)
Open Access | Times Cited: 6
P.G.M. de Gooyer, Y.L. Verschoor, L.D.W. van den Dungen, et al.
Nature Medicine (2024)
Open Access | Times Cited: 6
Showing 6 citing articles:
Personalizing Perioperative Chemotherapy in Colon Cancer
Joyce Pang, Caterina Baldi, Daniel O. Herzig
Clinics in Colon and Rectal Surgery (2025)
Closed Access
Joyce Pang, Caterina Baldi, Daniel O. Herzig
Clinics in Colon and Rectal Surgery (2025)
Closed Access
Molecular and functional profiling unravels targetable vulnerabilities in colorectal cancer
Efstathios‐Iason Vlachavas, Konstantinos Voutetakis, Vivian Kosmidou, et al.
Molecular Oncology (2025)
Open Access
Efstathios‐Iason Vlachavas, Konstantinos Voutetakis, Vivian Kosmidou, et al.
Molecular Oncology (2025)
Open Access
Current efficacy of immune checkpoint inhibitors in microsatellite unstable colorectal cancer and potential biomarkers
Mariam Rojas, Clara Ugueto Rodrigo, Reinaldo Moreno, et al.
(2025) Vol. 4
Open Access
Mariam Rojas, Clara Ugueto Rodrigo, Reinaldo Moreno, et al.
(2025) Vol. 4
Open Access
CITRINO: phase 1 dose escalation study of anti-LAG-3 antibody encelimab alone or in combination with anti-PD-1 dostarlimab in patients with advanced/metastatic solid tumours
J. Randolph Hecht, Jean‐Marie Michot, David J. Bajor, et al.
BJC Reports (2025) Vol. 3, Iss. 1
Open Access
J. Randolph Hecht, Jean‐Marie Michot, David J. Bajor, et al.
BJC Reports (2025) Vol. 3, Iss. 1
Open Access
Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation precision oncology to patients
Wafik S. El‐Deiry, Catherine Bresson, Fanny Wunder, et al.
Oncotarget (2025) Vol. 16, Iss. 1, pp. 140-162
Open Access
Wafik S. El‐Deiry, Catherine Bresson, Fanny Wunder, et al.
Oncotarget (2025) Vol. 16, Iss. 1, pp. 140-162
Open Access
Overview on biomarkers for immune oncology drugs
Evgeny N. Imyanitov, Elena V. Preobrazhenskaya, Natalia V. Mitiushkina
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access
Evgeny N. Imyanitov, Elena V. Preobrazhenskaya, Natalia V. Mitiushkina
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access
Neoadjuvant Immunotherapy Followed by Surgery Compared with Upfront Surgery Alone in Operable Colon Cancer with Deficient Mismatch Repair: Modeling Oncological Outcomes and Numbers Needed to Treat
Kanani Arezo, Veen Torhild, Lea Dordi, et al.
Annals of Surgical Oncology (2024)
Open Access | Times Cited: 1
Kanani Arezo, Veen Torhild, Lea Dordi, et al.
Annals of Surgical Oncology (2024)
Open Access | Times Cited: 1
Neoadjuvant combination immunotherapy in MSI/dMMR colorectal cancer
Meggy Suarez‐Carmona, Niels Halama
Trends in cancer (2024)
Open Access
Meggy Suarez‐Carmona, Niels Halama
Trends in cancer (2024)
Open Access
